<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">101702</article-id><article-id pub-id-type="doi">10.7554/eLife.101702</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>TPR is required for cytoplasmic chromatin fragment formation during senescence</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-385405"><name><surname>Bartlett</surname><given-names>Bethany M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1999-7675</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-385406"><name><surname>Kumar</surname><given-names>Yatendra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-279539"><name><surname>Boyle</surname><given-names>Shelagh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-385408"><name><surname>Chowdhury</surname><given-names>Tamoghna</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0004-6287-7227</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-385409"><name><surname>Quintanilla</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-385410"><name><surname>Boumendil</surname><given-names>Charlene</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1953-3902</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-385411"><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7989-7329</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-255213"><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6660-7735</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Genetics and Cancer</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Institute for Regeneration and Repair</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution>Institute of Biomedicine and Biotechnology of Cantabria</institution>, <addr-line><named-content content-type="city">Santander</named-content></addr-line>, <country>Spain</country></aff><aff id="aff4"><institution content-type="dept">Institute of Human Genetics</institution>, <institution>Université de Montpellier</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13674"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Reviewing editor</role><aff><institution>National Cancer Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>juan.acosta@unican.es</email> (JA);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>wendy.bickmore@ed.ac.uk</email> (WB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e101702</elocation-id><history><date date-type="received"><day>24</day><month>07</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>© 2024, Bartlett et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Bartlett et al</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-101702-v2.pdf"/><abstract><p>During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme - the senescence associated secretory phenotype (SASP) - driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00007/2</award-id><principal-award-recipient><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00035/7</award-id><principal-award-recipient><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>217120/Z/19/Z</award-id><principal-award-recipient><name><surname>Kumar</surname><given-names>Yatendra</given-names></name><name><surname>Bickmore</surname><given-names>Wendy A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C47559/A16243</award-id><principal-award-recipient><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Ministry of Science and Innovation, Government of Spain</institution></institution-wrap></funding-source><award-id>Proyecto PID2020-117860GB-I00</award-id><principal-award-recipient><name><surname>Acosta</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-21-CE12-0039</award-id><principal-award-recipient><name><surname>Boumendil</surname><given-names>Charlene</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The RNA-seq and ATAC-seq data generated in this study have been deposited in NCBI GEO, but the data are currently private. Access tokens for reviewers to access these submission data are:RNA seqhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264387Access token: qzihsgiwhlqvzopATAC seqhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264390Access token: irstugcgzfqrlib</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Bickmore WA</collab><collab>et al</collab></person-group><year iso-8601-date="2024">2024</year><source>TPR is required for cytoplasmic chromatin fragment formation during senescence</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264387">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264387</ext-link><comment>NCBI Gene Expression Omnibus, GSE264387</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Bickmore WA</collab><collab>et al</collab></person-group><year iso-8601-date="2024">2024</year><source>TPR is required for cytoplasmic chromatin fragment formation during senescence</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264390">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264390</ext-link><comment>NCBI Gene Expression Omnibus, GSE264390</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Parry et al</collab></person-group><year iso-8601-date="2018">2018</year><source>H3K27ac ChIP-seq</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103590">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103590</ext-link><comment>NCBI Gene Expression Omnibus, GSE103590</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-101702-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>